Exparel liposomal



This medicine is authorised for use in the European Union.


Exparel liposomal is a local anaesthetic that is used to treat pain after certain operations. It can be used in adults and children aged 6 years or older for local pain relief by injecting it around the edges of small to medium-sized surgical wounds. It is also used in adults for regional pain relief by injecting it around the nerves that supply the lower limbs or the shoulder. Exparel liposomal contains the active substance bupivacaine.

This EPAR was last updated on 14/11/2022

Authorisation details

Product details
Exparel liposomal
Agency product number
Active substance
International non-proprietary name (INN) or common name
Therapeutic area (MeSH)
Acute Pain
Anatomical therapeutic chemical (ATC) code
Publication details
Marketing-authorisation holder
Pacira Ireland Limited
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Pacira Ireland Limited
Unit 13, Dundrum Business Park
Classon House
Dublin 14
D14 W9Y3

Product information

07/11/2022 Exparel liposomal - EMEA/H/C/004586 - II/0005

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Amides
  • Anesthetics, local

Therapeutic indication

Exparel liposomal is indicated:

  • in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain.
  • in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Assessment history

Related content

How useful was this page?

Add your rating
2 ratings